Core Viewpoint - The article discusses the ongoing legal battles faced by Yitong Century (宜通世纪) following its acquisition of Beitai Health, highlighting recent developments in both criminal and civil cases related to the acquisition fraud, and the company's current state of having no controlling shareholder. Group 1: Legal Developments - Yitong Century has been pursuing legal action for seven years after acquiring Beitai Health for 1 billion yuan, which led to significant financial losses due to fraud [1][3]. - Recent updates include a criminal judgment against a co-defendant, who was sentenced to five years in prison and ordered to return 40 million yuan to Yitong Century [3][4]. - The civil case seeking 580 million yuan in damages has been sent back for retrial and accepted by the court, marking a procedural win for Yitong Century [6][7]. Group 2: Financial Implications - The total potential value of Yitong Century's claims, including criminal and civil cases, amounts to approximately 1.39 billion yuan [1]. - Despite the criminal ruling, the execution of the compensation remains uncertain due to the defendant's financial issues, with previous attempts to recover funds yielding minimal results [6][10]. - Yitong Century's financial performance has been declining, with a reported revenue of 2.502 billion yuan in 2024, down 5.93% year-on-year, and a net loss of approximately 30.35 million yuan [10][11]. Group 3: Corporate Governance - Yitong Century recently announced the dissolution of the agreement among its three controlling shareholders, resulting in a state of having no controlling shareholder [8]. - This change in governance occurs amidst the ongoing fallout from the acquisition fraud, leaving the company in a vulnerable position [8][16]. - The company has been focusing on its core business areas, such as telecommunications and IoT, after divesting Beitai Health in 2019 [8][11].

Core Viewpoint - Yitong Century announced that the company and its subsidiaries have no external guarantees, no overdue guarantees, and no amounts related to guarantees involved in litigation or losses due to adverse judgments [2] Summary by Categories - **Company Guarantees** - The company confirmed that it and its subsidiaries do not have any external guarantees [2] - There are no overdue guarantees reported [2] - **Litigation and Financial Liabilities** - The company stated that there are no amounts related to guarantees involved in any litigation [2] - There are no losses that the company needs to bear due to adverse judgments related to guarantees [2]

关于涉及诉讼事项的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 1、案件所处的诉讼阶段：已收到案件重审的《受理案件通知书》 2、上市公司所处的当事人地位：案件重审原告 证券代码：300310 证券简称：宜通世纪 公告编号:2025-048 宜通世纪科技股份有限公司 3、是否对上市公司损益产生的影响：因重审尚未开庭，暂无法判断对公司 损益的影响。 宜通世纪科技股份有限公司（以下简称"公司"或"宜通世纪"）于 2025 年 11 月 20 日收到广东省广州市中级人民法院出具的案件重审的《受理案件通知书》。 根据《深圳证券交易所创业板股票上市规则》关于信息披露的相关规定，现将涉 及的诉讼进展事项公告如下： 一、诉讼事项的基本情况 因深圳市倍泰健康测量分析技术有限公司（以下简称"倍泰健康"）原法定代 表人、实际控制人方炎林在宜通世纪并购倍泰健康过程中对公司实施合同诈骗， 为维护公司和全体股东的合法权益，公司依法向广州市中级人民法院提起诉讼， 请求法院撤销公司在并购倍泰健康时与交易对方签署的资产购买协议及补充协 议，判令各交易对方返还其因该购 ...

证券代码：300310 证券简称：宜通世纪 公告编号：2025-049 宜通世纪科技股份有限公司 关于为控股子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 宜通世纪科技股份有限公司（以下简称"公司"）于 2025 年 3 月 28 日分别召 开了第五届董事会第十一次（2024 年度）会议以及第五届监事会第九次（2024 年度）会议，会议审议通过了《关于为控股子公司提供担保的议案》，同意公司 为广东众益鼎新能源技术有限公司（以下简称"众益鼎"）及其下属项目公司向银 行或其他金融机构申请项目贷款担保，总额不超过人民币 8,000 万元连带责任担 保，担保的期限自公司董事会审议通过之日起的 12 个月内有效，最终担保金额 和期限以担保方和金融机构签署的担保协议为准。具体内容详见公司于 2025 年 4 月 1 日在巨潮资讯网披露的《关于为控股子公司提供担保的公告》（公告编号： 2025-013）。 2025 年 6 月 12 日，众益鼎全资子公司广州海枢新能源有限公司（以下简称 "海枢新能源"）因生产经营的需要，与兴业银行 ...

Core Viewpoint - The recent court ruling against Xu Mouqun in the financial fraud case related to the acquisition of Beitai Health by Yitong Century Technology Co., Ltd. highlights the increasing judicial efforts to combat financial fraud in China, emphasizing both the principal offenders and accomplices in such schemes [1][4]. Group 1: Case Background - Yitong Century initiated a major asset restructuring in 2016, acquiring 100% of Beitai Health for a total consideration of 1 billion yuan, with a commitment from the sellers to achieve a cumulative net profit of no less than 311 million yuan from 2016 to 2019 [2]. - In 2017, Beitai Health, under the direction of its original controllers, fabricated orders leading to financial misstatements in Yitong Century's 2017 annual report, resulting in administrative penalties from the China Securities Regulatory Commission [2][3]. Group 2: Judicial Outcomes - Xu Mouqun was sentenced to five years in prison and fined 500,000 yuan for his role in the fraud, which included providing funds and assisting in the financial deception that caused significant economic losses to Yitong Century [1][3]. - The court ordered the recovery of 40 million yuan from Xu's illegal gains to be returned to Yitong Century, with additional compensation required if the recovered amount was insufficient [1]. Group 3: Regulatory Environment - The case reflects a broader trend in China's regulatory environment, where the China Securities Regulatory Commission has begun to hold accomplices accountable alongside primary offenders in financial fraud cases, reinforcing a multi-faceted accountability system [4][6]. - Recent cases indicate a shift towards more stringent penalties for both the main perpetrators and those who assist in financial fraud, aiming to dismantle the ecosystem that supports such illegal activities [7][8].

Core Viewpoint - Yitong Century Technology Co., Ltd. has received a criminal judgment from the Guangzhou Intermediate People's Court regarding a long-standing merger and acquisition financial fraud case, marking a significant step in judicial accountability against financial fraud in China [1][2]. Group 1: Case Background - In 2016, Yitong Century initiated a major asset restructuring, acquiring 100% of Shenzhen Beitai Health Measurement Analysis Technology Co., Ltd. for a total consideration of 1 billion yuan, with a commitment from the sellers to achieve a cumulative net profit of no less than 311 million yuan from 2016 to 2019 [2]. - The fraud involved the fabrication of orders by Beitai Health, leading to financial misstatements in Yitong Century's 2017 annual report, resulting in administrative penalties from the China Securities Regulatory Commission [2]. Group 2: Judicial Outcomes - The court sentenced Xu Mouqun to five years in prison and imposed a fine of 500,000 yuan for his role in the fraud, which included providing funds and assisting in financial deception, causing significant economic losses to Yitong Century [1][3]. - The court also ordered the recovery of 40 million yuan in illegal gains from Xu, with provisions for further compensation if the recovery was insufficient [1]. Group 3: Regulatory Environment - The case reflects a broader trend in China's regulatory environment, emphasizing a dual approach of targeting both the principal offenders and accomplices in financial fraud cases, thereby enhancing market integrity and protecting investors' rights [1][4]. - The China Securities Regulatory Commission has reinforced its stance on punishing accomplices in financial fraud, indicating a shift towards a more comprehensive accountability framework [4][6]. Group 4: Industry Implications - The increasing severity of penalties for financial fraud, including criminal charges against accomplices, aims to deter potential fraudsters and purify the market environment [8][9]. - The establishment of a multi-dimensional accountability system is intended to create clear behavioral boundaries for market participants, thereby safeguarding investors' legitimate rights and interests [8][9].

Market Overview - On November 20, the communication services sector rose by 0.57% compared to the previous trading day, with Yitong Century leading the gains [1] - The Shanghai Composite Index closed at 3931.05, down 0.4%, while the Shenzhen Component Index closed at 12980.82, down 0.76% [1] Stock Performance - Yitong Century (300310) closed at 6.37, up 5.99% with a trading volume of 880,900 shares and a transaction value of 556 million [1] - ST Tongmai (603559) closed at 60.8, up 5.06% with a trading volume of 33,900 shares [1] - Chaoxun Communication (603322) closed at 48.45, up 3.15% with a trading volume of 118,900 shares and a transaction value of 569 million [1] - Other notable gainers include Jingtong Holdings (300292) and Huichang Communication (300578), with increases of 3.02% and 2.92% respectively [1] Fund Flow Analysis - The communication services sector saw a net inflow of 55.01 million from institutional investors, while retail investors contributed a net inflow of 157 million [2] - However, speculative funds experienced a net outflow of 212 million [2] Individual Stock Fund Flow - China Unicom (600050) had a net inflow of 217 million from institutional investors, but a net outflow of 107 million from speculative funds [3] - Yitong Century (300310) saw a net inflow of 108 million from institutional investors, with a significant net outflow from retail investors amounting to 97.79 million [3] - Aofei Data (300738) experienced a net inflow of 10.2 million from institutional investors, while retail investors had a net outflow of 65.31 million [3]

Core Viewpoint - The court ruling against Xu Guanqun for contract fraud has significant implications for Yitong Century, which is currently awaiting the outcome of the appeal process [1][2]. Group 1: Legal Proceedings - On November 18, Yitong Century received a criminal judgment from the Guangzhou Intermediate People's Court, sentencing Xu Guanqun to five years in prison and a fine of 500,000 RMB for contract fraud [1]. - The court found that Xu Guanqun's actions during the asset acquisition process led to Yitong Century overpaying for the acquired entity, resulting in substantial economic losses [2]. - Xu Guanqun has appealed the ruling, leaving the final judgment and its execution uncertain [2]. Group 2: Historical Context - The case traces back to a 2016 acquisition where Yitong Century paid 1 billion RMB to acquire 100% of Beitai Health, with a commitment from the sellers for a minimum net profit of 311 million RMB from 2016 to 2019 [4]. - Beitai Health's performance deteriorated over time, revealing hidden debt issues and leading to the investigation of its executives for alleged criminal activities [4][5]. - Yitong Century reported a significant goodwill impairment of over 500 million RMB in its 2018 half-year results due to the underperformance of Beitai Health [5]. Group 3: Financial Implications - The acquisition of Beitai Health resulted in a goodwill of approximately 756 million RMB, which poses a risk of substantial impairment for Yitong Century if further losses are confirmed [4]. - The hidden debt of 70 million RMB associated with Beitai Health was uncovered, leading to legal actions for repayment [6]. - Yitong Century has initiated legal proceedings to rescind the purchase agreement and recover the cash paid for the acquisition [7].

Core Viewpoint - The court ruling against Xu Guanqun for contract fraud has significant implications for Yitong Century, which is currently awaiting the outcome of the appeal process [1][2]. Group 1: Legal Proceedings - On November 18, Yitong Century received a criminal judgment from the Guangzhou Intermediate People's Court, sentencing Xu Guanqun to five years in prison and a fine of 500,000 RMB for contract fraud [1]. - The court found that Xu Guanqun's actions during the asset acquisition process led to Yitong Century overpaying for the acquired entity, resulting in substantial economic losses [2]. - Xu Guanqun has appealed the ruling, leaving the final judgment and subsequent execution uncertain [2]. Group 2: Historical Context - The case traces back to September 30, 2016, when Yitong Century acquired 100% of Beitai Health for 1 billion RMB, with an additional 482 million RMB raised for supporting funds [4]. - Beitai Health's performance fell short of expectations, revealing hidden debt issues and leading to legal troubles for its executives [4][5]. - The acquisition resulted in goodwill of approximately 756 million RMB, which poses a risk of significant impairment for Yitong Century if the situation worsens [4]. Group 3: Financial Impact - Following the legal issues, Yitong Century anticipated a goodwill impairment of about 500 million to 550 million RMB, projecting a net loss of 468 million RMB for the first half of 2018 [5][6]. - The hidden debt of 70 million RMB from Beitai Health, which was not disclosed during the acquisition, further complicates the financial outlook for Yitong Century [7]. - Yitong Century has initiated legal action against the shareholders of Beitai Health to recover the cash consideration paid during the acquisition [8].

宜通世纪（300310）11月18日晚发布关于收到《刑事判决书》的公告。根据公告，2016年公司收购倍泰 健康相关的合同诈骗案一审宣判，被告人许冠群因在并购过程中协助财务造假、造成公司重大损失，被 广州市中级人民法院以合同诈骗罪判处有期徒刑五年，并处罚金50万元。 一审获刑五年并被追缴4000万元 牵涉并购纠纷案件 据公告，上述案件牵涉的是此前宜通世纪在收购倍泰健康过程中遭遇合同诈骗的案件。 2016年10月，宜通世纪通过发行股份及支付现金的方式购买倍泰健康100%股权，交易对价为10亿元。 在收购完成后，宜通世纪发现，方炎林在并购中存在涉嫌犯罪行为，遂向广州市公安机关报案，公安机 关依法以涉嫌合同诈骗犯罪立案。 为维护公司和全体股东的合法权益，宜通世纪向广州市中院提起诉讼，请求撤销公司在并购倍泰健康时 与交易对方签署的资产购买协议及补充协议，判令各交易对方返还其因该购买协议所获得的财产给公 司，并且赔偿公司因此受到的损失。 2023年7月7日，广州市中院出具《民事判决书》，驳回了宜通世纪的全部诉讼请求以及所有被告的反诉 请求。2024年11月，宜通世纪向广东省高级人民法院提起上诉。 2025年11月3日，宜 ...